Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by SAMIR HANASH and AYUMU TAGUCHI.
SAMIR HANASH
Connection Strength
7.938
AYUMU TAGUCHI
  1. A Promising CPS1 Inhibitor Keeping Ammonia from Fueling Cancer. Cell Chem Biol. 2020 03 19; 27(3):253-254.
    View in: PubMed
    Score: 0.753
  2. Failure to Disclose Potential Conflict of Interest-Letter of Explanation. JAMA Oncol. 2019 12 01; 5(12):1811.
    View in: PubMed
    Score: 0.738
  3. MAPRE1 as a plasma biomarker for early-stage colorectal cancer and adenomas. Cancer Prev Res (Phila). 2015 Nov; 8(11):1112-9.
    View in: PubMed
    Score: 0.550
  4. Mouse to human blood-based cancer biomarker discovery strategies. Cold Spring Harb Protoc. 2014 Feb 01; 2014(2):144-9.
    View in: PubMed
    Score: 0.493
  5. Unleashing the power of proteomics to develop blood-based cancer markers. Clin Chem. 2013 Jan; 59(1):119-26.
    View in: PubMed
    Score: 0.451
  6. Integration of proteomics into systems biology of cancer. Wiley Interdiscip Rev Syst Biol Med. 2012 Jul-Aug; 4(4):327-37.
    View in: PubMed
    Score: 0.432
  7. Application of proteomics to cancer early detection. Cancer J. 2011 Nov-Dec; 17(6):423-8.
    View in: PubMed
    Score: 0.421
  8. The grand challenge to decipher the cancer proteome. Nat Rev Cancer. 2010 09; 10(9):652-60.
    View in: PubMed
    Score: 0.389
  9. Circulating microRNA Panel for Prediction of Recurrence and Survival in Early-Stage Lung Adenocarcinoma. Int J Mol Sci. 2024 Feb 16; 25(4).
    View in: PubMed
    Score: 0.247
  10. SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas. J Natl Cancer Inst. 2022 02 07; 114(2):290-301.
    View in: PubMed
    Score: 0.215
  11. Identification of Blood-Based Biomarkers for the Prediction of the Response to Neoadjuvant Chemoradiation in Rectal Cancer. Cancers (Basel). 2021 Jul 20; 13(14).
    View in: PubMed
    Score: 0.207
  12. A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer. J Natl Cancer Inst. 2019 04 01; 111(4):372-379.
    View in: PubMed
    Score: 0.176
  13. Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity. Nat Commun. 2019 01 16; 10(1):254.
    View in: PubMed
    Score: 0.174
  14. Plasma-derived extracellular vesicle proteins as a source of biomarkers for lung adenocarcinoma. Oncotarget. 2017 Nov 10; 8(56):95466-95480.
    View in: PubMed
    Score: 0.158
  15. MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway. Cancer Res. 2017 08 15; 77(16):4414-4425.
    View in: PubMed
    Score: 0.156
  16. Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer. J Natl Cancer Inst. 2017 04 01; 109(4).
    View in: PubMed
    Score: 0.153
  17. Switching Roles of TGF-? in Cancer Development: Implications for Therapeutic Target and Biomarker Studies. J Clin Med. 2016 Nov 30; 5(12).
    View in: PubMed
    Score: 0.150
  18. Deciphering the complexity of the cancer proteome for diagnostic applications. Expert Rev Mol Diagn. 2016; 16(4):399-405.
    View in: PubMed
    Score: 0.142
  19. Serum Glycans as Risk Markers for Non-Small Cell Lung Cancer. Cancer Prev Res (Phila). 2016 Apr; 9(4):317-23.
    View in: PubMed
    Score: 0.141
  20. Diacetylspermine Is a Novel Prediagnostic Serum Biomarker for Non-Small-Cell Lung Cancer and Has Additive Performance With Pro-Surfactant Protein B. J Clin Oncol. 2015 Nov 20; 33(33):3880-6.
    View in: PubMed
    Score: 0.137
  21. Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma. J Natl Cancer Inst. 2015 Aug; 107(8).
    View in: PubMed
    Score: 0.135
  22. Molecular portraits of epithelial, mesenchymal, and hybrid States in lung adenocarcinoma and their relevance to survival. Cancer Res. 2015 May 01; 75(9):1789-800.
    View in: PubMed
    Score: 0.133
  23. Proteomic signatures associated with p53 mutational status in lung adenocarcinoma. Proteomics. 2014 Dec; 14(23-24):2750-9.
    View in: PubMed
    Score: 0.130
  24. A search for novel cancer/testis antigens in lung cancer identifies VCX/Y genes, expanding the repertoire of potential immunotherapeutic targets. Cancer Res. 2014 Sep 01; 74(17):4694-705.
    View in: PubMed
    Score: 0.127
  25. Pro-surfactant protein B as a biomarker for lung cancer prediction. J Clin Oncol. 2013 Dec 20; 31(36):4536-43.
    View in: PubMed
    Score: 0.121
  26. Circulating pro-surfactant protein B as a risk biomarker for lung cancer. Cancer Epidemiol Biomarkers Prev. 2013 Oct; 22(10):1756-61.
    View in: PubMed
    Score: 0.119
  27. Comprehensive proteomic profiling of aldehyde dehydrogenases in lung adenocarcinoma cell lines. Int J Proteomics. 2011; 2011:145010.
    View in: PubMed
    Score: 0.105
  28. Lung cancer signatures in plasma based on proteome profiling of mouse tumor models. Cancer Cell. 2011 Sep 13; 20(3):289-99.
    View in: PubMed
    Score: 0.104
  29. A Comprehensive Search of Non-Canonical Proteins in Non-Small Cell Lung Cancer and Their Impact on the Immune Response. Int J Mol Sci. 2022 Aug 11; 23(16).
    View in: PubMed
    Score: 0.056
  30. Mutational Activation of the NRF2 Pathway Upregulates Kynureninase Resulting in Tumor Immunosuppression and Poor Outcome in Lung Adenocarcinoma. Cancers (Basel). 2022 May 21; 14(10).
    View in: PubMed
    Score: 0.055
  31. Novel urinary protein biomarker panel for early diagnosis of gastric cancer. Br J Cancer. 2020 11; 123(11):1656-1664.
    View in: PubMed
    Score: 0.049
  32. The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling. Gastroenterology. 2020 12; 159(6):2146-2162.e33.
    View in: PubMed
    Score: 0.048
  33. Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer. Gut. 2020 10; 69(10):1818-1831.
    View in: PubMed
    Score: 0.047
  34. Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer. Nature. 2019 04; 568(7752):410-414.
    View in: PubMed
    Score: 0.044
  35. Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins. JAMA Oncol. 2018 10 01; 4(10):e182078.
    View in: PubMed
    Score: 0.043
  36. HIV Infection and Circulating Levels of Prosurfactant Protein B and Surfactant Protein D. J Infect Dis. 2018 01 17; 217(3):413-417.
    View in: PubMed
    Score: 0.041
  37. Role of CPS1 in Cell Growth, Metabolism and Prognosis in LKB1-Inactivated Lung Adenocarcinoma. J Natl Cancer Inst. 2017 03 01; 109(3):1-9.
    View in: PubMed
    Score: 0.038
  38. A statistical method for detecting differentially expressed SNVs based on next-generation RNA-seq data. Biometrics. 2017 03; 73(1):42-51.
    View in: PubMed
    Score: 0.036
  39. Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome. Proc Natl Acad Sci U S A. 2016 Mar 15; 113(11):E1555-64.
    View in: PubMed
    Score: 0.036
  40. Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2. Mol Cell. 2016 Feb 18; 61(4):640.
    View in: PubMed
    Score: 0.035
  41. Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2. Mol Cell. 2016 Feb 18; 61(4):520-534.
    View in: PubMed
    Score: 0.035
  42. Systemic Metabolomic Changes in Blood Samples of Lung Cancer Patients Identified by Gas Chromatography Time-of-Flight Mass Spectrometry. Metabolites. 2015 Apr 09; 5(2):192-210.
    View in: PubMed
    Score: 0.033
  43. CDKN2A/p16 inactivation mechanisms and their relationship to smoke exposure and molecular features in non-small-cell lung cancer. J Thorac Oncol. 2013 Nov; 8(11):1378-88.
    View in: PubMed
    Score: 0.030
  44. Enrichment strategies in glycomics-based lung cancer biomarker development. Proteomics Clin Appl. 2013 Oct; 7(9-10):664-76.
    View in: PubMed
    Score: 0.030
  45. Integrated mass spectrometry-based analysis of plasma glycoproteins and their glycan modifications. Nat Protoc. 2011 Mar; 6(3):253-69.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.